参考文献/References:
［1］Major FJ, Blessing JA, Silverberg SG, et al. Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group study ［J］. Cancer,1993,71(S4):1702-1709.
［2］Friedlander ML, Covens A, Glasspool RM, et al. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mullerian Adenosarcoma of the Female Genital Tract ［J］. International Journal of Gynecological Cancer,2014,24(9 Suppl 3):S78-82.
［3］肖雪，陈敦金，刘娟，等.青年期子宫苗勒管腺肉瘤2例临床诊治分析 ［J］.广东医学，2013，34(24)：3751-3753.
［4］戴莘悦，陈金嫣，陈海燕，等.子宫腺肉瘤3例 ［J］.实用妇产科杂志，2015，31(9):699-700.
［5］McCluggage W. Mullerian adenosarcoma of the female genital tract ［J］. Advances in anatomic pathology，2010，17(2):122-129.
［6］徐阳，赵凡桂，张浩，等.mullerian腺肉瘤的临床及超声特点分析［J］.实用妇产科杂志，2015，31（10）：762-765.
［7］Santos P, Cunha T. Uterine sarcomas: clinical presentation and MRI features ［J］. Diagnostic and Interventional Radiology，2015，21(1):4-9.
［8］Gallardo A, Prat J. Mullerian adenosarcoma: A clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma［J］. American Journal of Surgical Pathology，2009，33(2):278-288.
［9］Clement PB, Scully RE. Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature［J］. Human Pathology，1990，21(4):363.
［10］Soslow RA, Ali A, Oliva E. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases ［J］. The American Journal of Surgical Pathology，2008，32(7):1013-1021.
［11］Park J, Kim D, Kim J, et al. The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus ［J］. Annals of Surgical Oncology，2011，18(12):3453-3461.
［12］邢娟，申震，周颖，等.子宫腺肉瘤的研究进展 ［J］.国际妇产科学杂志，2017，44（5）：499-502.
［13］韩肖燕，向阳.苗勒管腺肉瘤诊治进展 ［J］.中华妇产科杂志，2009，44（6）:478-480.
［14］Tanner EJ, Toussaint T, Leitao MM, et al. Management of uterine adenosarcomas with and without sarcomatous overgrowth ［J］. Gynecologic Oncology，2013，129(1):140-144.